Cost of Managing Type  2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database

ConclusionDespite an initial increase in healthcare expenditure, concomitant with reevaluation of patient care, this study showed that initiation of DPP4Is as an add-on therapy in French patients with T2D was associated with care expenditure that was in line or below predicted values within the 3  years following treatment initiation. Additional studies are required to evaluate the economic impact of the long-term treatment benefits.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research